Superselective Citicoline And Verapamil for Ischemic Neuroprotection and Greater Effective Response (SCAVINGER) in the Kentucky Regional Population: A Clinical and Translational Study
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Citicoline (Primary) ; Verapamil (Primary)
- Indications Stroke
- Focus Adverse reactions
- Acronyms SCAVINGER
- 21 Sep 2016 Planned End Date changed from 1 Feb 2018 to 1 Sep 2016.
- 21 Sep 2016 Planned primary completion date changed from 1 Feb 2018 to 1 Sep 2016.
- 21 Sep 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.